The global facial injectables market is anticipated to grow at a considerable CAGR of around 10.5% during the forecast period (2022-2028). The growing demand for filler procedures over the past years attributed to various people are currently tending towards improved aesthetic beauty and also several novel fillers are in development. Furthermore, surging R&D initiatives for the new product development of various fillers has led to launches of improved and more beneficial products. These new product launches along with better results are factors for the global facial injectable market growth. For instance, in August 2020, Revance Therapeutics, Inc., launched the RHA Collection of dermal fillers, along with an integrated fintech platform, HintMD this are developed for the correction of dynamic facial wrinkles and various folds that are moderate to severe, such as nasolabial folds among others. RHA 2 and RHA 3 fillers are used effectively in the superficial and mid-dermis for the treatment of perioral and marionette lines. RHA 4 filler is used for volumizing, in this, the treated areas remain the same supple, and treatment results natural-looking.
Browse the full report description of “Global Facial Injectables Market Size, Share & Trends Analysis Report By Type (Collagen, Hyaluronic Acid (HA), Botulinum Toxin Type A, Calcium Hydroxylapatite (CaHA), Polymethylmethacrylate Beads (PMMA Microspheres), Poly-L-Lactic Acid (PLLA), and Others), By Application (Lip Augmentation, Face Lift & Correction, Acne Scar Treatment, Lipoatrophy Treatment, and Others), By End-User (Hospitals, Cosmetic Clinic, and, Others) Forecast Period (2022-2028)” at https://www.omrglobal.com/industry-reports/facial-injectables-market
Similarly, in June 2020, Allergan Aesthetics launched, JUVÉDERM® VOLUMA™ XC for the augmentation of the chin region to improve the chin profile in adults over the age of 21. JUVÉDERM® Collection of Fillers has the broadest portfolio of specifically tailored treatment is the first and only filler to receive U.S. FDA approval.
Market Coverage
• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
o By Type
o By Application
o By End-User
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
1.1. Competitive Landscape- Allergan Australia Pty Ltd, Ipsen Pharma, Medytox Inc, Merz Pharma GmbH & Co.KGaA, Sinclair Pharma, Suneva Medical, S&V Technologies GmbH, Teoxane SA, and others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Facial Injectables Market Report by Segment
By Type
By Application
By End-User
Global Facial Injectables Market Report by Region
North America
• US
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle Ea
• st & Africa
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/facial-injectables-market